976 resultados para (S)-9-methylgermacrene-B


Relevância:

30.00% 30.00%

Publicador:

Resumo:

A serologic response to hepatitis B virus (HBV) defined as 'anti-HBc alone' is commonly observed, but its significance remains unclear. This study aimed to define the relationship between 'anti-HBc alone' serostatus and HBV infection, including HBV-specific T- and B-cell memory responses. We enrolled 31 'anti-HBc alone' patients. Total HBV DNA and cccDNA were tested by nested polymerase chain reaction (PCR) analysis in liver samples from 22 'anti-HBc alone' patients vs controls (chronic or resolved HBV infection), followed by HBsAg/HBcAg immunohistochemical (IHC) staining. IFN-γ secretion by HBV-specific T cells was compared in individuals who were 'anti-HBc alone' (n = 27), resolved HBV (n = 21), chronic HBV (n = 24) and 12 healthy controls using enzyme-linked immunospot (ELISpot) assays. An HBsAg-IgG B-cell ELISpot assay was performed in 'anti-HBc alone' patients before and after one dose of recombinant HBsAg vaccine. The majority (23/31, 74.2%) of the 'anti-HBc alone' individuals were co-infected with HCV. Infrequent intrahepatic total HBV DNA (2/22, 9.1%) and cccDNA (1/22, 4.5%) were detected in biopsies; HBsAg and HBcAg IHC staining was negative. HBV-specific T-cell responses were similar between 'anti-HBc alone' individuals and HBV resolvers. Circulating HBV-memory B-cell responses were detected in all 'anti-HBc alone' individuals, consistent with an HBsAg-specific memory pool. After one HBV vaccine dose, increased anti-HBs antibody levels were observed, accompanied by an expansion of HBsAg-specific memory B cells (P = 0.0226). 'Anti-HBc alone' individuals showed HBV-specific T-cell and memory B-cell responses typical of previous viral exposure and protective memory, suggesting a resolved infection.

Relevância:

30.00% 30.00%

Publicador:

Resumo:

BACKGROUND Few data on the virological determinants of hepatitis B virus (HBV) infection are available from southern Africa. METHODS We enrolled consecutive HIV-infected adult patients initiating antiretroviral therapy (ART) at two urban clinics in Zambia and four rural clinics in Northern Mozambique between May 2013 and August 2014. HBsAg screening was performed using the Determine® rapid test. Quantitative real-time PCR and HBV sequencing were performed in HBsAg-positive patients. Risk factors for HBV infection were evaluated using Chi-square and Mann-Whitney tests and associations between baseline characteristics and high level HBV replication explored in multivariable logistic regression. RESULTS Seventy-eight of 1,032 participants in Mozambique (7.6%, 95% confidence interval [CI]: 6.1-9.3) and 90 of 797 in Zambia (11.3%, 95% CI: 9.3-13.4) were HBsAg-positive. HBsAg-positive individuals were less likely to be female compared to HBsAg-negative ones (52.3% vs. 66.1%, p<0.001). Among 156 (92.9%) HBsAg-positive patients with an available measurement, median HBV viral load was 13,645 IU/mL (interquartile range: 192-8,617,488 IU/mL) and 77 (49.4%) had high values (>20,000 UI/mL). HBsAg-positive individuals had higher levels of ALT and AST compared to HBsAg-negative ones (both p<0.001). In multivariable analyses, male sex (adjusted odds ratio: 2.59, 95% CI: 1.22-5.53) and CD4 cell count below 200/μl (2.58, 1.20-5.54) were associated with high HBV DNA. HBV genotypes A1 (58.8%) and E (38.2%) were most prevalent. Four patients had probable resistance to lamivudine and/or entecavir. CONCLUSION One half of HBsAg-positive patients demonstrated high HBV viremia, supporting the early initiation of tenofovir-containing ART in HIV/HBV-coinfected adults.

Relevância:

30.00% 30.00%

Publicador:

Resumo:

OBJECTIVE In 2013, Mozambique adopted Option B+, universal lifelong antiretroviral therapy (ART) for all pregnant and lactating women, as national strategy for prevention of mother-to-child transmission of HIV. We analyzed retention in care of pregnant and lactating women starting Option B+ in rural northern Mozambique. METHODS We compared ART outcomes in pregnant ("B+pregnant"), lactating ("B+lactating") and non-pregnant-non-lactating women of childbearing age starting ART after clinical and/or immunological criteria ("own health") between July 2013 and June 2014. Lost to follow-up was defined as no contact >180 days after the last visit. Multivariable competing risk models were adjusted for type of facility (type 1 vs. peripheral type 2 health center), age, WHO stage and time from HIV diagnosis to ART. RESULTS Over 333 person-years of follow-up (of 243 "B+pregnant", 65″B+lactating" and 317 "own health" women), 3.7% of women died and 48.5% were lost to follow-up. "B+pregnant" and "B+lactating" women were more likely to be lost in the first year (57% vs. 56.9% vs. 31.6%; p<0.001) and to have no follow-up after the first visit (42.4% vs. 29.2% vs. 16.4%; p<0.001) than "own health" women. In adjusted analyses, risk of being lost to follow-up was higher in "B+pregnant" (adjusted subhazard ratio [asHR]: 2.77; 95% CI: 2.18-3.50; p<0.001) and "B+lactating" (asHR: 1.94; 95% CI: 1.37-2.74; p<0.001). Type 2 health center was the only additional significant risk factor for loss to follow-up. CONCLUSIONS Retaining pregnant and lactating women in option B+ ART was poor; losses to follow-up were mainly early. The success of Option B+ for prevention of mother-to-child transmission of HIV in rural settings with weak health systems will depend on specific improvements in counseling and retention measures, especially at the beginning of treatment. This article is protected by copyright. All rights reserved.

Relevância:

30.00% 30.00%

Publicador:

Resumo:

Text, Übers. u. Erklärung nebst e. textkrit. Anhang von Karl Albrecht

Relevância:

30.00% 30.00%

Publicador:

Resumo:

Text, Übers. u. Erklärung nebst e. textkrit. Anhang von Karl Marti u. Georg Beer

Relevância:

30.00% 30.00%

Publicador:

Resumo:

Text, Übers. u. Erklärung nebst e. textkrit. Anhang von Oskar Holtzmann

Relevância:

30.00% 30.00%

Publicador:

Resumo:

11 Briefe zwischen M. Gosling und Max Horkheimer, 1935-1938; 1 Brief von Ellen Gottschalk an 04.08.1936; 1 Brief von Brill an Max Horkheimer, 15.08.1936; 2 Briefe zwischen Louise Gottschalk und Max Horkheimer, 06.12.1937, 19.04.1937; 3 Briefe zwischen Max Gottschalk und Max Horkheimer, 1941, 23.01.1941; 2 Briefe zwischen Nemes Gottschalk und Max Horkheimer, 29.03.1939, 03.04.1939; 2 Briefe zwischen Lawrence Gould und Max Horkheimer, 12.01.1947, 04.01.1947; 4 Briefe zwischen Isaeque Graeber und Max Horkheimer, 20.07.1941, 1941; 4 Briefe zwischen Malborne W. Graham und Max Horkheimer, 17.10.1940, 1940; 1 Brief von Max Horkheimer an J. A. C. Grant, 23.10.1940; 2 Briefe zwischen dem Grant Grove Lodge Kings Canyon National Park California und Max Horkheimer, 30.09.1946, 04.10.1946; 4 Brefe zwischen Liesel Gras und Max Horkheimer, 1948, 02.04.1948; 2 Briefe zwischen Claire F. Gravel und 23.03.1942, 26.03.1942; 1 Brief und 4 Briefentwürfe von Max Horkheimer an Edward S. Greenbaum, 20.06.1940; 13 Briefe zwischen B. Groethuysen und Max Horkheimer, 1935-1937; 1 Hochzeitsanzeige von Isabelle Grossen, 26.11.1938; 1 Brief von Max Horkheimer an Isabelle Grossen, 17.12.1938; 1 Brief von Kurt Grossmann an Max Horkheimer, 29.12.1939; 3 Briefe von Eva Grosz an Max Horkheimer, 1937; 5 Briefe zwischen Franz M. Groedel und Max Horkheimer, 1939, Oktober 1939; 7 Briefe zwischen Emil Grünberg und Max Horkheimer, 1935-1940; 1 Brief von B. M. Telders an Max Horkheimer, 27.09.1938; 3 Briefe zwischen dem Academic Assistance Council London und Max Horkheimer, 1935, 29.03.1935; 1 Briefentwurft von Max Horkheimer an Karl Grünberg, 07.02.1936; 1 Brief von Juliette Favez an Max Horkheimer, 07.02.1936; 3 Briefe zwsichen Martin Grünberg und Max Horkheimer, November 1938, 18.11.1938; 3 Briefe zwischen Alfred Grünebaum und Max Horkheimer, 10.01.1939, 1939; 2 Briefe zwischen D. E. Grünebaum und Max Horkheimer, 24.11.1940, 02.12.1940; 3 Briefe zwischen Richard Güldenstein und Max Horkheimer, August 1937, 17.08.1937; 1 Brief von Daniel Guérin an Max Horkheimer, 13.07.1947; 1 Brief von Max Horkheimer an Guerro, 08.09.1936;

Relevância:

30.00% 30.00%

Publicador:

Resumo:

del S. Telemann. [Textverf.: Gottfried Simonis]

Relevância:

30.00% 30.00%

Publicador:

Resumo:

Signatur des Originals: S 36/F11111